论文部分内容阅读
在西德放射研究协会血液学研究所的主持下(组织委员会主任Thierfelder.S),1979年3月8～10日于慕尼黑召开了以骨髓移植免疫生物学新动向为主题的国际讨论会。现将讨论会中提出的一些论文简报如下(会议录另行刊出)。骨髓移植对若干恶性血液系统疾患,尤其是急性白血病和再生障碍性贫血的治疗,尽管在不久之前,仍然不过是一种实验性的治疗,或者只是对晚期患者列为最后考虑的尝试,但是近年来确已逐渐成为一种极为有效的方法。取得这一进步的理由,主要是病例的选择较好;对移植前免疫抑制剂的使用较为个体化,以及对病人有较好的护理经验等。另一方面,
Under the chairmanship of the Western Institute of Radiation Research Institute of Hematology (Thierfelder.S, Director of the Organizational Committee), an international symposium was held on March 8-10, 1979, in Munich, focusing on new trends in the immunobiology of bone marrow transplantation. Some of the papers presented in the seminar are as follows (the proceedings will be published separately). The treatment of a number of hematologic malignancies, especially acute leukemia and aplastic anemia, by bone marrow transplantation, although only a short time ago, is still an experimental treatment or is only an attempt to be considered as a final consideration for advanced patients. However, Indeed, it has become an extremely effective method. The reasons for this progress are mainly the better selection of cases, the more individualized use of immunosuppressants prior to transplantation, and better nursing experience for patients. on the other hand,